Search results
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
AOL· 12 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of the ever-evolving coronavirus called JN ...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
KEYT 3 Santa Barbara· 14 hours agoGovernment advisers say it’s time to update the recipe for the COVID-19 vaccines Americans will...
FDA objects to ecstasy for treating PTSD patients
The Washington Times· 21 hours agoLykos Therapeutics and the Multidisciplinary Association for Psychedelic Studies tested the psychedelic drug, which can heighten feelings of intimacy and...
FDA panel rejects ecstasy to treat PTSD
The Week via Yahoo News· 21 hours agoLykos CEO Amy Emerson said the company is "disappointed in the vote" but will continue working with the FDA to meet the "urgent need for new, effective...
MDMA therapy wait goes on as FDA panel rejects Lykos’ PTSD treatment
Pharmaceutical Technology via Yahoo Finance· 1 day agoA US Food and Drug Administration (FDA) panel has voted to decline approval of Lykos Therapeutics's...
FDA advisory panel votes against MDMA for treatment of PTSD
PhillyVoice.com· 21 hours ago"Participants appear to experience rapid, clinically meaningful, durable improvement in their PTSD...
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe US Food and Drug Administration (FDA) has granted orphan drug designation to Be Biopharma’s (Be...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 3 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
FDA Panel Says No to MDMA as Treatment for PTSD | FOX 28 Spokane
FOX 28 Spokane· 24 hours agoMelissa Decker Barone, a psychologist with the Department of Veterans Affairs, said during the...
JD Supra: FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and...
JD Supra· 18 hours agoOn April 25, 2024, the FDA published a notice of availability in the Federal Register for its revised draft guidance, entitled “Promotional Labeling and Advertising Considerations ...
